Here are what the editors at HealthDay consider to be the most important developments in Pulmonology for June 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
U.S. Could See 100,000 New Cases of COVID-19 Each Day, Fauci Says
TUESDAY, June 30, 2020 (HealthDay News) — Top U.S. infectious disease expert Anthony Fauci, M.D., warned Congress on Tuesday that COVID-19 infections could climb to 100,000 new cases daily unless ongoing outbreaks are contained.
FBI Warns of Scammers Selling Fake COVID-19 Antibody Tests
TUESDAY, June 30, 2020 (HealthDay News) — Fake or unapproved COVID-19 antibody tests are being sold by scammers, the Federal Bureau of Investigation warns.
Updated Guidance Provided for Safe Solid Organ Transplantation
TUESDAY, June 30, 2020 (HealthDay News) — Updated recommendations for reducing transmission of HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV) through transplantation include universal solid organ donor nucleic acid testing, according to research published in the June 26 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Heart Rhythm Disorders Seen in Critically Ill COVID-19 Patients
TUESDAY, June 30, 2020 (HealthDay News) — Critically ill patients with COVID-19 are more likely to develop heart rhythm disorders than other hospitalized patients, according to a study published online June 22 in Heart Rhythm.
Mild Fever, Little Respiratory Illness Seen With COVID-19-Positive Infants
TUESDAY, June 30, 2020 (HealthDay News) — Babies with COVID-19 generally have mild illness, with mostly fever, according to a brief report published online June 17 in The Journal of Pediatrics.
Latinos Have High Rate of Positivity for SARS-CoV-2
TUESDAY, June 30, 2020 (HealthDay News) — The rate of positivity for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is over 40 percent for Latinos in the Baltimore-Washington D.C. region, according to a research letter published online June 18 in the Journal of the American Medical Association.
COVID-19 Drug Remdesivir Could Cost Up to $3,120 Per Patient
MONDAY, June 29, 2020 (HealthDay News) — Gilead Sciences, the maker of remdesivir, the first drug that showed promise in treating COVID-19 infections, will charge U.S. hospitals $3,120 for a patient with private insurance, the company announced Monday.
Many Practice Unsafe Household Cleaning Against COVID-19
MONDAY, June 29, 2020 (HealthDay News) — More than one-third of U.S. adults admit to unsafe cleaning practices in the hopes of disinfecting against COVID-19, according to research published in the June 12 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Early Respiratory Infections Linked to Atopic Dermatitis Diagnosis 
Cognitive, Manual Impairment Tied to Unacceptable Inhaler Technique 
Vitamin A, D May Aid Asthma Outcomes 
Consensus Statements Developed for Rheumatoid Arthritis-Linked Interstitial Lung Disease 
Exposure to Air Pollutants Linked to Increased RA Disease Activity 
Timing of JAK Initiation, Shingles Vaccine Administration Can Affect Outcomes in RA 
Longer Persistence Seen With Upadacitinib Versus TNFi in Rheumatoid Arthritis 
Mesothelioma Diagnoses and Deaths Still Increasing 
